Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities

The authors critically reviewed published lists of nanoobjects and their physico-chemical properties deemed important for risk assessment and discussed metrological challenges associated with the development of nanoscale reference materials (RMs). Five lists were identified that contained 25 (classes of) nano-objects; only four (gold, silicon dioxide, silver, titanium dioxide) appeared on all lists. Twenty-three properties were identified for characterisation; only (specific) surface area appeared on all lists. The key themes that emerged from this review were: 1) various groups have prioritised nano-objects for development as “candidate RMs” with limited consensus; 2) a lack of harmonised terminology hinders accurate description of many nano-object properties; 3) many properties identified for characterisation are ill-defined or qualitative and hence are not metrologically traceable; 4) standardised protocols are critically needed for characterisation of nano-objects as delivered in relevant media and as administered to toxicological models; 5) the measurement processes being used to characterise a nano-object must be understood because instruments may measure a given sample in a different way; 6) appropriate RMs should be used for both accurate instrument calibration and for more general testing purposes (e.g., protocol validation); 7) there is a need to clarify that where RMs are not available, if “(representative) test materials” that lack reference or certified values may be useful for toxicology testing and 8) there is a need for consensus building within the nanotechnology and environmental, health and safety communities to prioritise RM needs and better define the required properties and (physical or chemical) forms of the candidate materials.

STEFANIAK Aleksandr;  HACKLEY Vince;  ROEBBEN Gert;  EHARA Kensei;  HANKIN Steve;  POSTEK Michael;  LYNCH Iseult;  FU Wei-En;  LINSINGER Thomas;  THUENEMANN Andreas; 

2013-11-25

INFORMA HEALTHCARE

JRC69336

1743-5390,   

http://informahealthcare.com/doi/abs/10.3109/17435390.2012.739664,    https://publications.jrc.ec.europa.eu/repository/handle/JRC69336,   

10.3109/17435390.2012.739664,